Themis Medicare (THEMISMED) | Stock Overview & Key Data
Themis Medicare Performance Comparison
Stock Range
Today's Range
Low: ₹108.35
High: ₹117.01
on August 8, 2025
52 Week Range
Low: ₹100.51
High: ₹317.00
on August 4, 2025
on November 18, 2024
All-Time High: ₹1,834.00 on September 25, 2023
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR10.3B
EPS
-0.99
P/E Ratio (TTM)
32.38
Forward P/E
N/A
P/B Ratio
2.56
PEG Ratio
-1.03
Div. Yield
0.37%
ROE
7.41%
Beta
-0.222
Debt to Equity
20.61
Financial Highlights
Profitability
Gross Margin
46.30%
Operating Margin
-12.95%
Profit Margin
-2.39%
Returns and Earnings
Return on Assets (TTM)
5.07%
Return on Equity (TTM)
7.41%
EBITDA
INR596.4M
Net Income (TTM)
INR-90.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR41.30
Quarterly Revenue Growth (YoY)
-20.70%
Quarterly Earnings Growth (YoY)
-20.66%
Dividend Information
Last 12-Month Dividend
₹0.50
Current Dividend Yield
0.37%
3-Year Average Dividend Yield
0.08%
3-Year Average Annual Dividend
₹0.20
3-Year Total Dividends
₹0.60
Ex-Dividend Date
July 12, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Themis Medicare THEMISMED | 10.31B Small-cap | 6.43% | -13.80% | -9.38% | -49.18% | -57.56% | -52.99% | -86.00% | -71.88% |
| Sun Pharmaceutical SUNPHARMA | 3.84T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
| Sun Pharma Advanced SPARC | 46.34B Small-cap | -4.83% | -8.86% | 0.02% | -8.70% | -28.94% | -34.79% | -34.46% | -20.13% |
| Aarti Drugs AARTIDRUGS | 44.83B Small-cap | 0.47% | 3.52% | 17.71% | 21.40% | 7.96% | -1.73% | 18.09% | -4.28% |
| Sequent Scientific SEQUENT | 42.04B Small-cap | -0.34% | -9.41% | 8.30% | 7.32% | -9.00% | 22.29% | 57.12% | 26.68% |
Ownership & Short Interest
Insider Ownership
75.81%
Institutional Ownership
0.07%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
702K
Average 90-Day Volume
328K
Themis Medicare Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Themis Medicare would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is THEMISMED's 52-week high and low?
- In the last 52 weeks, Themis Medicare reached a high of ₹317.00 (on November 18, 2024) and a low of ₹100.51 (on August 4, 2025).
- What is the market cap and P/E ratio for THEMISMED?
- Curious about Themis Medicare's size and valuation? Its market capitalization stands at 10.31B. When it comes to valuation, the P/E ratio (trailing twelve months) is 32.38, and the forward P/E (looking ahead) is N/A.
- Does THEMISMED pay dividends? If so, what's the yield?
- Yes, Themis Medicare is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.37%, and the company has paid an average of ₹0.20 per share annually over the past 3 years.
- Who are Themis Medicare's main competitors or similar companies to consider before investing?
When looking at Themis Medicare, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.84T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% Sun Pharma Advanced
SPARC46.34B Healthcare Drug Manufacturers - Specialty & Generic -34.79% -34.46% Aarti Drugs
AARTIDRUGS44.83B Healthcare Drug Manufacturers - Specialty & Generic -1.73% 18.09% Sequent Scientific
SEQUENT42.04B Healthcare Drug Manufacturers - Specialty & Generic 22.29% 57.12% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Themis Medicare Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Themis Medicare's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 7.41%, the Debt to Equity ratio from the most recent quarter is 20.61, and its Gross Profit Margin stands at 46.30%.
- What is the recent revenue and earnings growth for THEMISMED?
- Looking at Themis Medicare's growth, its revenue over the trailing twelve months (TTM) was INR4B. Compared to the same quarter last year (YoY), quarterly revenue grew by -20.70%, and quarterly earnings saw a YoY growth of -20.66%.
- How much of THEMISMED stock is held by insiders and institutions?
- Wondering who owns Themis Medicare stock? Company insiders (like executives and directors) hold about 75.81% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.07%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.